Ventricular Assist Device (VAD) and Total Artificial Heart (TAH)

Date Added: 24 September 2019, 10:38
Last Updated Date:06 November 2019, 16:26

For patients with end-stage heart failure, the pumping function of the heart is done through an advanced technology artificial heart device.

A Ventricular Assist Device can remain from a few days to a couple of weeks in cases of acute cardiac insufficiency due to viral infections in patients or reanimation after the heart stops, or even years if necessary.

Patients who are Suitable for a Ventricular Assist Device
Patients who have or have recently been diagnosed with end-stage heart failure are suitable for Ventricular Assist Devices.
While Ventricular Assist Devices are used to prevent possible problems with other organ functions, they can be also be used to keep patients alive in cases where cardiac insufficiency develops due to heart muscle infection.

Ventricular Assist Devices can also be used for patients on the heart transplant waiting list as a protective measure. Ventricular Assist Devices are used to increase the patient’s life quality and duration in cases where the patient has an advanced age and has cardiac insufficiency accompanied by other severe illnesses and is not suitable for heart transplants.

Total Artificial Heart
The diseased heart is replaced with a Total Artificial Heart in cases where the blood circulation around the body cannot be achieved even with Ventricular Assist Devices. This procedure is performed by completely removing the diseased heart from the body and replacing it with an artificial heart device.